| Term 
 | Definition 
 
        | Aminoglycoside Broad (mostly neg)
 MOA: Inhibit protein synthesis (30s)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aminoglycoside Broad (mostly neg)
 MOA: Inhibit protein synthesis (30s)
 Pseudomonas DOC
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aminoglycoside Broad (mostly neg)
 MOA: Inhibit protein synthesis (30s)
 Significant allergic response. Comes in Neosporin ointment/sol. (with polymixin B and either bacitracin or gramicidin) CAN BE USED IN COMBO FOR ACANTHAMOEBA
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Aminoglycoside Broad (mostly neg)
 MOA: Inhibit protein synthesis (30s)
 Only injectable into eye
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tetracycline Broad, +rickettsia and chlamydia
 MOA: Inhibit protein synthesis (30s)
 Also anti-inflammatory
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tetracycline Broad, +rickettsia and chlamydia
 MOA: Inhibit protein synthesis (30s)
 Also anti-inflammatory
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tetracycline Broad, +rickettsia and chlamydia
 MOA: Inhibit protein synthesis (30s)
 Also anti-inflammatory
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Macrolide Narrow, mostly gram+ Rickettsia, H.flu, chlamydia. Resistance common
 MOA: Inhibit protein synthesis (50s)
 DOC for legionnaires. Ophthalmic versions are ointment only.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Macrolide Broad. gram+/- and chlamydia
 MOA: Inhibit protein synthesis (50s)
 DOC for chlamydia (1g). Comes as azasite. Possible anti-inflammatory effect.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Macrolide Staph/strep skin infection and sinusitis
 MOA: Inhibit protein synthesis (50s)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Other Mostly gram +, anaerobic gram - and MRSA
 MOA: Inhibit protein synthesis (50s)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Other Broad, rickettsia, chlamydia. Pseudomonas is resistant
 MOA: inhibit protein synthesis (50s)
 Good corneal penetration but harsh side effects (gray baby syndrome, bone marrow issues) ALSO causes optic neuritis (edema, hemes, optic atrophy), decreased VA, central scotomas
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: Inhibit cell wall synthesis Narrow, gram + (few gram -)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicillin Gram +, neisseria and treponema
 MOA: inhibit cell wall synthesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicllin G+
 MOA: inhibit cell wall synthesis
 Penicillinase resistant
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicllin G+
 MOA: inhibit cell wall synthesis
 Penicillinase resistant
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicllin G+
 MOA: inhibit cell wall synthesis
 Penicillinase resistant
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicllin G+
 MOA: inhibit cell wall synthesis
 Penicillinase resistant
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicillin Extended spectrum (mostly g+, some g-)
 MOA: inhibit cell wall synthesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicillin Extended spectrum (mostly g+, some g-)
 MOA: inhibit cell wall synthesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicillin Gram+, anti-pseudomonal
 MOA:inhibit cell wall synthesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Penicillin Gram+, anti-pseudomonal
 MOA:inhibit cell wall synthesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cephalosporin Gram +, neisseria
 MOA:inhibit cell wall synthesis
 1st gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cephalosporin Gram +, neisseria
 MOA:inhibit cell wall synthesis
 1st gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cephalosporin Gram +, neisseria
 MOA:inhibit cell wall synthesis
 1st gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cephalosporin Gram +, neisseria
 MOA:inhibit cell wall synthesis
 1st gen
 IV
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cephalosporin Gram +, neisseria, some g-
 MOA:inhibit cell wall synthesis
 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cephalosporin Gram +, neisseria, some g-
 MOA:inhibit cell wall synthesis
 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cephalosporin Gram +, neisseria, some g-
 MOA:inhibit cell wall synthesis
 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cephalosporin More gram -, less gram +. better for MRSA than other cephalosporins
 MOA:inhibit cell wall synthesis
 3rd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cephalosporin More gram -, less gram +. better for MRSA than other cephalosporins
 MOA:inhibit cell wall synthesis
 3rd gen
 Can be fortified
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mostly gram +cocci/bacilli MOA: inhibit cell wall
 Lots of side effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: disrupts bacterial membrane structure Narrow, gram- including enteric rods. 2ns choice for pseudomonas
 Great in combination
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA: Inhibit cell membrane Gram +
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fluoroquinolone broad (most g+ resistant)
 MOA: disrupt DNA synthesis and supercoiling
 2nd gen
 Precipitates in cornea
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fluoroquinolone broad (most g+ resistant)
 MOA: disrupt DNA synthesis and supercoiling
 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fluoroquinolone broad (most g+ resistant)
 MOA: disrupt DNA synthesis and supercoiling
 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fluoroquinolone broad (most g+ resistant)
 MOA: disrupt DNA synthesis and supercoiling
 3rd gen
 Comes as 1.5% (Iquix)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fluoroquinolone broad more gram + than others
 MOA: disrupt DNA synthesis and supercoiling.Mess with DNA gyrase and topoisomerase
 4th gen
 Can come self-preserved
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fluoroquinolone broad, more gram+ than others
 MOA: disrupt DNA synthesis and supercoiling.Mess with DNA gyrase and topoisomerase
 4th gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chloro-Fluoroquinolone broad, more gram + than others and less resistance
 MOA: disrupt DNA synthesis and supercoiling. Mess with DNA gyrase and topoisomerase
 4th gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chemotherapeutic agent Broad, more gram+
 MOA: inactivates dihydrofolate reductase
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chemotherapeutic agent Sulfonamide
 Wide spectrum. Resistance in US
 MOA: interrupts bacterial folic acid synthesis by competing with PABA
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chemotherapeutic agent Sulfonamide
 Wide spectrum. Resistance in US
 MOA: interrupts bacterial folic acid synthesis by competing with PABA
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiviral Inhibits DNA synthesis
 Thymidine analog
 DOC for HSEK
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiviral Inhibits DNA synthesis
 Gel For HSVEK. Less frequent dosing, less tocixity (targets virus)
 Can be used for adenovirus in theory
 Oral for CMV
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiviral Produg activated by HSV thymidine kinase
 Can be used prophylactically or for acute HSK or HZO
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiviral Prodrug of acyclovir
 Better bioavailability
 Can be used for prophylaxis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ANtiviral Inhibits viral DNA
 For genital and ophthalmic HSV
 Pro-drug of penciclovir
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antifungal (topical) Broad spectrum (candida, aspergillus etc)
 Only FDA approved treatment
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-fungal Can be formulated into topical, but usually systemic
 Toxic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Treatment of acanthamoeba |  | 
        |  | 
        
        | Term 
 
        | Polyhexamethylene biguanide |  | Definition 
 
        | Treatment of acanthamoeba |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Kills everything Very toxic to eye
 Pre-surgical or for adenovirus (EKC)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ester-steroid Less IOP increase, less cataracts etc.
 Comes in drop (0.5%),preservative free ointment,and now gel (few shakes)
 Comes in 0.2% for allergies (alrex)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ketone Steroid Acetate, alcohol, phosphate (strongest to weakest)
 Potent
 Comes as an oral (for mild to severe inflammation)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ketone steroid Acetate=Flarex, alcohol=FML, phosphate (strongest to weakest)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ketone steroid Acetate, alcohol, phosphate (strongest to weakest)
 Strongest steroid response!
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Prednisolone derivate with better potency, lipophilicity, and better anti-inflammatory affect. NO SHAKE (emulsion). |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ketone soft steroid Inactivated metabolite of pred
 Strong but poor penetrance (so weak action)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Injectable steroid (usually periocular) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Injectable steroid Used for chalazia and post-seg stuff
 Comes as an implant for diabetic macular edema
 Available orally for moderate inflammation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dexamethazone implant for macular edema following vein occlusions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fluocinolone acetonide implant (operating room) for chronic uveitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Fluocinolone acetonide implant (in office) for Diabetic ME |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ganciclovir implant for CMV retinitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tobramycin and loteprednol Potent steroid/antibiotic
 Good for s. aureus.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Gentamicin and pred acetate Potent steroid/antibiotic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tobramycin and dexamethasone Potent steroid/antibiotic
 comes in ST form which has less IOP affects and is a suspension with xanthan gum (longer retention)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | neomycin, polymyxin B, and pred acetate Potent sensitizing antibiotic and strong steroid.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | neomycin, polymyxin B and dexamethasone potent sensitizing antibiotic and weak steroid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Neomycin polymyxin b and hydrocortisone Potent sensitizing antibiotic and VERY weak steroid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mast cell stabalizer 1st gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mast cell stabalizer 1st gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mast cell stabalizer 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mast cell stabalizer 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dual action allergy med Either pataday (0.2%) or patanol (0.1%)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dual action allergy med Comes as Zaditor, Alaway, Refrsh Eye Itch Relief, Claritin and Zyrtec EYE
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rx dual action allergy med |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rx dual action allergy med |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nasal allergy spray that works for eye allergies. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classical topical NSAID Peripheral acting analgesic
 Can be used for allergy relief (also available PF and in LS form for less sting)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mildly sedating oral antihistimine 1st gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mildly sedating oral antihistimine 1st gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Minimally sedating oral antihistamine 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Minimally sedating oral antihistamine 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Minimally sedating oral antihistamine 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Minimally sedating oral antihistamine 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Minimally sedating oral antihistamine 2nd gen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mildly sedating oral antihistamine Benedryl
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antihistimine/vasoconstrictor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antihistimine/vasoconstrictor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antihistimine/vasoconstrictor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Immunosuppressive agent Good for dry eye and off label for allergies
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anesthetic and mydriatic Blocks NE reuptake (indirect adrenergic)
 Causes mydriasis and vasoconstriction
 Used to diagnose horners
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anesthetic More sting than benoxinate or proparacaine
 Contraindicated with sulfonamides
 Comes in viscous sol.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anesthetic Only available with NaFl
 For tono
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anesthetic Popular in optometry
 Available with NaFl.
 Less sting
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Preservative free amide anesthetic (if akten) Also comes in a patch and as an injectable.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cream anesthetic. Good for post herpetic neuralgia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Often combined with anesthetic to decrease bleeds and systemic absorbtion. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mydriatic Direct acting adrenergic
 Good vasoconstrictor, can be used for horner's and ptosis. 10% problematic with heart issues and have drug interactions.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mydriatic Indirect acting adrenergic
 Increases NE release from nerve terminal
 Also inhibits NE reuptake
 Can cause vasoconstriction. Few systemic side effects topically. May also be used in horner's. Available in paramyd (combo with tropicamide)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Reverses dilation from phenyl or hydroxyamphetamine. Causes redness and ptosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cyclopegic Works 7-12 days
 For uveitis, accomodative esotropes or to break synechiae. Has overdose risk (hot as a hare, mad as a hatter, dry as a bone, red as a beet). 20 drops of 1% fatal to children
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cycloplegic Works 5-7 days
 May be better for people with dark irides
 For uveities, synechiae or an alternate to atropine. MORE toxicity risk (central).
 Available as a motion sickness patch
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cycloplegic Works 1-3 days
 DOC for uveitis and atropine-sensitivity. Long dilation time and poor cycloplegic potency
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cycloplegic Works 24 hours
 DOC for cycloplegic refraction. Comes in a spray. Less SE in 1%
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cycloplegic Works 4-6 hours
 Poor effect in a red eye. Used in combination (with anesthetic increases effect). DM patients resistent without phenyl. Less impacted by iris pigmentation, increased concentration doesn't increase dilation.
 Mostly for dilation! Safe with heart probs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classic topical NSAID Peripheral acting analgesic
 Acetic acid non-salicylate
 Generics can cause corneal melt in sick eyes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | New topical opthalmic NSAID (better anti-inflammatory) Peripheral acting analgesic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | New topical opthalmic NSAID (better anti-inflammatory) Peripheral acting analgesic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral NSAID Cox-2 inhibitor
 Peripheral acting analgesic
 Ceiling effect
 May increase risk of heart attack/stroke
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral non-salicylate NSAID Propionic acid
 Peripheral acting analgesic
 Ceiling effect
 More effective than aspirin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral non-salicylate NSAID Propionic acid
 Peripheral acting analgesic
 50 mg q4g equal to tylenol with codeine. Good for ocular pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral non-salicylate NSAID Propionic acid
 Peripheral acting analgesic
 May be safer because mostly cox-2
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral non-salicylate NSAID Acetic acid
 Peripheral acting analgesic
 Causes corneal deposits (stromal specks and whorl-k) and retinal pigment scattering/depigmentation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral NSAID Peripheral acting analgesic
 Pyrrolo-pyrrole
 Strongest. Only post surgical
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral NSAID Peripheral acting analgesic
 Anthranilic acid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral NSAID Peripheral acting analgesic
 Fenolic acid
 57 hr half life
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Narcotic (central acting) Modest analgesic, moderate sedative
 Often combined with NSAIS and aspirin
 |  | 
        |  | 
        
        | Term 
 
        | Acetaminophen (tylenol/APAP) |  | Definition 
 
        | Non-narcotic analgesic Maybe central acting
 Analgesic and antipyretic
 Toxicity possible and causes liver,kidney and heart probs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Narcotic (central acting) Modest analgesic, mild sedative
 Comes in combos with acetaminophen aspirin and ibuprofen (vicoden, lortab, vicoprofen)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Central acting analgesic Non-scheduled med .
 Lower risk of abuse, interact with MAOI
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-convulsant Changes the way the body senses pain
 Good for post-herpetic neuralgia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adjuvant No direct analgesic affect but increases effect of NSAID/narcotics
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Analgesic Anti-inflammatory
 Peripheral acting analgesic
 Anti-pyretic and anti-platelet activity
 Causes Reye's in sick kids
 |  | 
        |  | 
        
        | Term 
 
        | Doan's pills (magnesium salicylate) |  | Definition 
 
        | Non-narcotic analgesic Less platelet activity, anti-inflammatory and GI issues than aspirin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-malarial Treats malaria and autoimmune disorders
 Causes whorl K (verticillata), glare/halos bullseye maculopathy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-psychotic Causes anterior subcapsular stellate cataracts (dense 3-9 point stars), fuzzy vision, halos
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cause chrysiasis (gold deposits in cornea and lens) Look similar to agryosis (from silver), chalcosis (copper), siderosis (iron) and bismuthiasis (bismuth)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Used to treat psoriasis/vitiligo Are photosensitizing and cause cataracts
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Used to treat cardiac arrhythmia Causes whorl-k (superficial, brownish similar to hudson stali line) also cause lens deposits, decrease VA
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Causes decreased corneal sensation, ulceration, injection, and vision loss. May have associated infection. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | May be used for many things including JRA Cause PSC
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Used for prostate issues Cause floppy iris syndrome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acne med Causes corneal opacities, neo, SPK, bleph, dry eye/CL intolerance, pseudotumor cerebri, birth defects, impaired dark adaptation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Used to treat TB Causes retrobulbar optic neuritis (decreased VA, color vision probs, VF loss)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Used for congestive heart failure Cause snowy vision, color vision issues and entopic phenomena
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-cancer drug Cause yellow/white refractile bodies in macular and edema, decreased VA, VF defect
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cause retinal emboli (tiny, yellow/white spots resulting in occlusions and neo) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Not used much anymore Causes CME, maybe decreased VA
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | For sexual arousal Causes vasodilation. mayb be related to NAION
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Prostaglandin analogue Increase uveoscleral outflow
 Less redness
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Prostaglandin analogue Increase uveoscleral outflow
 Better for african americans
 Maintains effects for 44 hours.
 BAK free
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Prostaglandin analogue Increase uveoscleral outflow
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Amide-based prostaglandin analogue (prostanoid) Increase uveoscleral outflow, (+/- outflow facility)
 Stings more
 Also available as latisse for eyelash growth
 |  | 
        |  | 
        
        | Term 
 
        | Timolol maleate (timoptic) |  | Definition 
 
        | Beta blocker Decrease aqueous production
 Gold standard
 Available PF (ocudose) and in gel. Istalol formulation is more lipophilic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta blocker Decrease aqueous production
 Cheaper than timoptic but brand name
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta blocker Decrease aqueous production
 Less effective but has intrinsic sympathomimetic activity ( less SE on depression/cholesterol)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta blocker Decrease aqueous production
 Beta 1 selective with calcium channel blocking effect/less vasoconstriction
 Less IOP drop but maintains VF better
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta blocker decrease aqueous production
 longest half life
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Epinephrine prodrug Acts as sympathomimetic
 Decrease aqueous production
 Allergy risk
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha 2 agonist Decrease aqueous production
 Not effective as a third med with B-blocker and CAI
 For ACG and to prevent IOP spike during surgery
 Allergy probs
 Tachyphylaxis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha 2 agonist Decrease aqueous production and increase uveoscleral outflow (dual action)
 Can cause lid redness and miosis in dim light. Available with b-blockers (combigan) and CAI (simbrinza) in combo.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CAI Decrease aqueous production
 Cannot add to latanoprost or oral CAI. Available in combo with timolol (cosopt)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CAI Decrease aqueous production
 Less SE
 Available in combo with brimonidine (sabrinza)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral CAI Decrease aqueous production
 More for angle closure, macular edema or as a diuretic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral CAI Decrease aqueous production
 less SE than diamox but still many and multiple contraindications (class wide)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hyperosmotic Decrease IOP by osmosis
 In emergency situations
 Warn diabetics of glucose load
 Causing vomiting! among other SE of dehydration
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hyperosmotic Decrease IOP by osmosis
 Safe for diabetics, IV only
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hyperosmotic Decrease IOP by osmosis
 Not safe for diabetics
 IV only
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Miotic direct acting Parasympathomimetic
 Increase aqueous outflow
 Better in light irides
 Available in gel or sol.
 Ok for angle closure. For non-presbyopes SE are significant. SLUD is SE in all people (rare)
 DOC for Pigment dispersion glaucoma
 Available as an insert (ocusert) which operates under zero order kinetics. Also comes with timolol as combo (rare)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Miotic Direct acting Parasympathomimetic
 Increase aqueous outflow
 Poor penetration, more SE. Surgery only
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Miotic Indirect acting long term
 late stage POAG and accomodative ET
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Miotic Indirect acting long term
 late stage POAG and accomodative ET and as an atropine poisoning reversal
 |  | 
        |  |